UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research

Value in health, 2016-12, Vol.19 (8), p.929-935

2016

Volltextzugriff (PDF)

Economic analysis of the prevalence and clinical and economic burden of medication error in England

BMJ quality & safety, 2021-02, Vol.30 (2), p.96-105

2021

Volltextzugriff (PDF)

The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought

Value in health, 2016-12, Vol.19 (8), p.921-928

2016

Volltextzugriff (PDF)

Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6

Value in health, 2012-09, Vol.15 (6), p.835-842

2012

Volltextzugriff (PDF)

Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold

Health technology assessment (Winchester, England), 2015-02, Vol.19 (14), p.1-504

2015

Volltextzugriff (PDF)

Reflecting the real value of health care resources in modelling and cost-effectiveness studies-The example of viral load informed differentiated care

PloS one, 2018-01, Vol.13 (1), p.e0190283-e0190283

2018

Volltextzugriff (PDF)

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine

JAMA : the journal of the American Medical Association, 2016-09, Vol.316 (10), p.1093

2016

Volltextzugriff (PDF)

Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS)

European urology, 2018-01, Vol.73 (1), p.23-30

2018

Volltextzugriff (PDF)

Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility

Health economics, 2005-05, Vol.14 (5), p.487-496

2005

Volltextzugriff (PDF)

Ideas About Resourcing Health Care in the United States: Can Economic Evaluation Achieve Meaningful Use?

Annals of internal medicine, 2021-01, Vol.174 (1), p.80-85

2021

Volltextzugriff (PDF)

Catalogue of EQ-5D Scores for the United Kingdom

Medical decision making, 2011-11, Vol.31 (6), p.800-804

2011

Volltextzugriff (PDF)

Model Parameter Estimation and Uncertainty Analysis: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group–6

Medical decision making, 2012-09, Vol.32 (5), p.722-732

2012

Volltextzugriff (PDF)

Clinical Trials Provide Essential Evidence, but Rarely Offer a Vehicle for Cost-Effectiveness Analysis

Value in health, 2015-03, Vol.18 (2), p.141-142

Sculpher, Mark, PhD

2015

Volltextzugriff (PDF)

Endovascular versus Open Repair of Abdominal Aortic Aneurysm

The New England journal of medicine, 2010-05, Vol.362 (20), p.1863-1871

2010

Volltextzugriff (PDF)

Health Opportunity Costs: Assessing the Implications of Uncertainty Using Elicitation Methods with Experts

Medical decision making, 2020-05, Vol.40 (4), p.448-459

2020

Volltextzugriff (PDF)

The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis: Conceptual Framework and Application

Medical decision making, 2014-11, Vol.34 (8), p.951-964

2014

Volltextzugriff (PDF)

Global Health Economics:Shaping Health Policy in Low- and Middle-Income Countries

2020

Volltextzugriff (PDF)

Value based pricing for NHS drugs: an opportunity not to be missed?

BMJ, 2008-02, Vol.336 (7638), p.251-254

International edition, 2008

Volltextzugriff (PDF)

Authors’ Response to: “Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al.” by Sampson, Firth, and Towse

Medical decision making, 2021-04, Vol.41 (3), p.258-260

2021

Volltextzugriff (PDF)

Developing a Value Framework: The Need to Reflect the Opportunity Costs of Funding Decisions

Value in health, 2017-02, Vol.20 (2), p.234-239

2017

Volltextzugriff (PDF)

Characterizing Structural Uncertainty in Decision Analytic Models: A Review and Application of Methods

Value in health, 2009-07, Vol.12 (5), p.739-749

2009

Volltextzugriff (PDF)

Using value of information analysis to prioritise health research: some lessons from recent UK experience

PharmacoEconomics, 2006, Vol.24 (11), p.1055-1068

2006

Volltextzugriff (PDF)

Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates

PLoS neglected tropical diseases, 2022-06, Vol.16 (6), p.e0010471-e0010471

2022

Volltextzugriff (PDF)

The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation

Health technology assessment (Winchester, England), 2016-11, Vol.20 (86), p.1-348

2016

Volltextzugriff (PDF)

Coverage with Evidence Development, Only in Research, Risk Sharing, or Patient Access Scheme? A Framework for Coverage Decisions

Value in health, 2012-05, Vol.15 (3), p.570-579

2012

Volltextzugriff (PDF)

1 – 25 von 353

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(328)
Mit Volltextzugriff
(296)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Pharmacoeconomics
(50)
Heart
(24)
Value In Health
(23)
Health Economics
(20)
Medical Decision Making
(20)
Bmj. British Medical Journal
(18)
Bmj
(17)
International Journal Of Technology Assessment In Health Care
(13)
Bmj : British Medical Journal
(8)
Health Technology Assessment
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research

Economic analysis of the prevalence and clinical and economic burden of medication error in England

The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought

Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6

Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold

Reflecting the real value of health care resources in modelling and cost-effectiveness studies-The example of viral load informed differentiated care

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine

Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS)

Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility

Ideas About Resourcing Health Care in the United States: Can Economic Evaluation Achieve Meaningful Use?

Catalogue of EQ-5D Scores for the United Kingdom

Model Parameter Estimation and Uncertainty Analysis: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group–6

Clinical Trials Provide Essential Evidence, but Rarely Offer a Vehicle for Cost-Effectiveness Analysis

Endovascular versus Open Repair of Abdominal Aortic Aneurysm

Health Opportunity Costs: Assessing the Implications of Uncertainty Using Elicitation Methods with Experts

The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis: Conceptual Framework and Application

Global Health Economics:Shaping Health Policy in Low- and Middle-Income Countries

Value based pricing for NHS drugs: an opportunity not to be missed?

Authors’ Response to: “Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al.” by Sampson, Firth, and Towse

Developing a Value Framework: The Need to Reflect the Opportunity Costs of Funding Decisions

Characterizing Structural Uncertainty in Decision Analytic Models: A Review and Application of Methods

Using value of information analysis to prioritise health research: some lessons from recent UK experience

Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates

The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation

Coverage with Evidence Development, Only in Research, Risk Sharing, or Patient Access Scheme? A Framework for Coverage Decisions

Suchergebnisse filtern